<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Iron deficiency anaemia (workup + referral triggers) — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Iron deficiency anaemia</h1>
        <div class="sub">Adults with iron deficiency anaemia (IDA): confirm iron deficiency, start iron replacement, screen for coeliac disease, use NICE NG12 FIT triage for suspected colorectal cancer, and refer/arrange GI investigation when indicated (BSG 2021 + NG12 2023).</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑11</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
<h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points (primary care)</strong>
                <ul>
                  <li><strong>Confirm iron deficiency before extensive investigation</strong> (unless unstable): ferritin is the single most useful test; consider transferrin saturation if ferritin may be falsely normal (inflammation) (BSG 2021).</li>
                  <li><strong>Colorectal cancer triage now uses FIT (NG12):</strong> offer quantitative FIT to guide referral in adults with <strong>iron deficiency anaemia</strong> (NG12, 2023). <strong>Refer on suspected cancer pathway</strong> if <strong>FIT ≥10 µg Hb/g faeces</strong> (NG12, 2023). If FIT not returned/negative, safety‑net and do not delay referral if strong clinical concern (NG12).</li>
                  <li><strong>Men + postmenopausal women</strong> with newly diagnosed unexplained IDA often warrant <strong>upper + lower GI investigation</strong> (gastroscopy + colonoscopy; CT colonography if colonoscopy unsuitable) (BSG 2021). (Note: this is broader than NG12 FIT triage, and local pathways may combine both.)</li>
                  <li><strong>Initial investigations recommended by BSG</strong> for confirmed IDA include <strong>urinalysis/urine microscopy</strong> and <strong>coeliac disease screening</strong>, plus GI endoscopy where appropriate (BSG 2021).</li>
                  <li><strong>Start iron replacement promptly:</strong> BSG advises iron therapy should not be deferred while awaiting investigations <strong>unless colonoscopy is imminent</strong>. Typical first‑line oral regimens: ferrous sulphate/fumarate/gluconate; once daily; if not tolerated consider every‑other‑day dosing or alternative/IV iron (BSG 2021).</li>
                </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;&lt;li&gt;(Add 1–3 background bullets if desired.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
                &lt;li&gt;Suspected &lt;strong&gt;major haemorrhage&lt;/strong&gt; (haematemesis/melaena/large PR bleed) or &lt;strong&gt;haemodynamic compromise&lt;/strong&gt;.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Symptomatic severe anaemia&lt;/strong&gt; with concerning features (e.g. syncope, chest pain, acute heart failure, severe breathlessness) → urgent assessment / ED.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;New neurological/cardiac ischaemia symptoms&lt;/strong&gt; possibly precipitated by anaemia.&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
                &lt;li&gt;Bleeding: GI symptoms, PR bleeding/melaena, haematemesis; menstrual losses; haematuria.&lt;/li&gt;
                &lt;li&gt;Dietary factors; recent pregnancy/postpartum; blood donation.&lt;/li&gt;
                &lt;li&gt;Malabsorption risks: coeliac symptoms/family history; bariatric surgery; chronic diarrhoea.&lt;/li&gt;
                &lt;li&gt;Medications: NSAIDs/aspirin/anticoagulants (bleeding risk); PPIs (possible reduced absorption).&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Coeliac disease screen&lt;/strong&gt; (serology) for confirmed IDA (BSG).&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Urinalysis&lt;/strong&gt; / urine microscopy (BSG).&lt;/li&gt;
                &lt;li&gt;Consider: pregnancy test where relevant; stool testing only if diarrhoea/infective features (not routine for IDA).&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;&lt;li&gt;(If no explicit ‘who not to refer’ applies, omit or keep minimal.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;&lt;li&gt;(Add references here.)&lt;/li&gt;&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
<h3>Iron deficiency anaemia (IDA) — adults: workup + referral triggers</h3>

              <h4>Immediate red flags (999 / ED now)</h4>
              <ul>
                <li>Suspected <strong>major haemorrhage</strong> (haematemesis/melaena/large PR bleed) or <strong>haemodynamic compromise</strong>.</li>
                <li><strong>Symptomatic severe anaemia</strong> with concerning features (e.g. syncope, chest pain, acute heart failure, severe breathlessness) → urgent assessment / ED.</li>
                <li><strong>New neurological/cardiac ischaemia symptoms</strong> possibly precipitated by anaemia.</li>
              </ul>

              <h4>Step 1 — confirm iron deficiency (don’t skip this)</h4>
              <ul>
                <li>FBC + indices (MCV/MCH), film if atypical.</li>
                <li><strong>Ferritin</strong> (most useful single marker). If inflammation suspected, add <strong>transferrin saturation</strong> / iron studies (BSG).</li>
                <li>Baseline: U&amp;Es, LFTs, CRP/ESR as clinically indicated; check B12/folate if mixed picture.</li>
              </ul>

              <h4>Step 2 — look for obvious causes (history + quick checks)</h4>
              <ul>
                <li>Bleeding: GI symptoms, PR bleeding/melaena, haematemesis; menstrual losses; haematuria.</li>
                <li>Dietary factors; recent pregnancy/postpartum; blood donation.</li>
                <li>Malabsorption risks: coeliac symptoms/family history; bariatric surgery; chronic diarrhoea.</li>
                <li>Medications: NSAIDs/aspirin/anticoagulants (bleeding risk); PPIs (possible reduced absorption).</li>
              </ul>

              <h4>Step 3 — start iron replacement (don’t wait unless colonoscopy imminent)</h4>
              <ul>
                <li>Start oral iron (e.g. ferrous sulphate/fumarate/gluconate) — <strong>one tablet daily</strong> (BSG). If not tolerated: <strong>every other day</strong> or alternative oral preparation; consider IV iron if oral is contraindicated/ineffective/not tolerated (BSG).</li>
                <li>Monitor response: check Hb response in the first few weeks; a brisk rise supports iron deficiency (BSG).</li>
                <li>Continue treatment for ~<strong>3 months after Hb normalises</strong> to replete stores (BSG).</li>
              </ul>

              <h4>Step 4 — minimum initial investigations (before/alongside referral)</h4>
              <ul>
                <li><strong>Coeliac disease screen</strong> (serology) for confirmed IDA (BSG).</li>
                <li><strong>Urinalysis</strong> / urine microscopy (BSG).</li>
                <li>Consider: pregnancy test where relevant; stool testing only if diarrhoea/infective features (not routine for IDA).</li>
              </ul>

              <h4>Step 5 — colorectal cancer triage (NICE NG12 2023 FIT framing)</h4>
              <ul>
                <li>Offer <strong>quantitative FIT</strong> to guide referral for suspected colorectal cancer in adults with <strong>iron deficiency anaemia</strong> (NG12).</li>
                <li>If <strong>FIT ≥10 µg Hb/g faeces</strong> → <strong>refer using suspected cancer pathway</strong> (NG12).</li>
                <li>If FIT is <strong>not returned</strong> or <strong>&lt;10</strong>:
                  <ul>
                    <li>Ensure <strong>safety‑netting</strong> (NG12).</li>
                    <li><strong>Do not delay referral</strong> if strong clinical concern (e.g. abdominal mass, ongoing unexplained symptoms) (NG12).</li>
                  </ul>
                </li>
                <li>Related pages: <a href="./change-in-bowel-habit.html">Change in bowel habit / suspected CRC</a>; <a href="./pr-bleeding.html">PR bleeding</a>.</li>
              </ul>

              <h4>Who to refer / where to send (D&amp;G placeholders)</h4>
              <ul>
                <li><strong>999 / ED</strong>: unstable/major bleeding; severe symptomatic anaemia with cardiorespiratory compromise.</li>
                <li><strong>Suspected cancer pathway (CRC)</strong>: FIT ≥10 (NG12).</li>
                <li><strong>Urgent gastro / direct-access endoscopy</strong> (local route):
                  <ul>
                    <li>Men and <strong>postmenopausal women</strong> with <strong>new unexplained IDA</strong> often warrant bidirectional endoscopy (BSG) (local pathway may be FIT-led or direct-to-endoscopy).</li>
                    <li>Ongoing IDA despite treatment; recurrent IDA; or additional alarm features (weight loss, change in bowel habit, abdominal mass).</li>
                  </ul>
                </li>
                <li><strong>Gynae / women’s health</strong>: heavy menstrual bleeding or other gynaecological bleeding as the likely source (plus treat IDA in parallel).</li>
                <li><strong>Haematology</strong>: atypical blood results (pancytopenia, haemolysis), unexplained microcytosis without iron deficiency, suspected haematological malignancy, or anaemia not responding as expected.</li>
              </ul>

              <h4>Referral-letter minimum (suggested)</h4>
              <ul>
                <li>Hb + indices, ferritin ± transferrin saturation, platelets; trend if available.</li>
                <li>Coeliac serology result; urinalysis result.</li>
                <li>FIT result (value + date), and whether sample was returned (NG12).</li>
                <li>Symptoms: GI (change in bowel habit, abdominal pain, weight loss, PR bleeding/melaena), gynae bleeding; any haematuria.</li>
                <li>Iron therapy started (drug/dose/date) and response if rechecked.</li>
              </ul>

              <h4>Local agreement needed (add D&amp;G specifics)</h4>
              <ul>
                <li class="check">Local policy for <strong>FIT in IDA</strong>: who orders, expected turnaround, and whether to start iron before FIT sample (pragmatically: start iron; but clarify if local instructions differ).</li>
                <li class="check">What to do with <strong>FIT &lt;10</strong> but confirmed IDA: urgent gastro clinic vs direct-to-endoscopy vs repeat FIT vs watchful waiting (and safety‑net timeline).</li>
                <li class="check">Default route for <strong>men/postmenopausal women</strong> with new unexplained IDA (FIT-first vs direct bidirectional endoscopy) and how this maps to “suspected cancer pathway”.</li>
                <li class="check">Local access to <strong>IV iron</strong> and transfusion thresholds/route for symptomatic anaemia (ED vs SDEC vs haematology).</li>
                <li class="check">Local preference for coeliac screening and any required additional tests before GI referral (e.g. repeat ferritin, CRP).</li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑06)</h3>
              <ol>
                <li>RCOG Green‑top Guideline No. 34: Ovarian Cysts in Postmenopausal Women (consensus update Dec 2025; web page last reviewed 05 Dec 2025). <a href="https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/ovarian-cysts-in-postmenopausal-women-green-top-guideline-no-34/">rcog.org.uk</a></li>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer (ovarian cancer section; CA‑125 ≥35 → USS). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">nice.org.uk</a></li>
                <li>Right Decisions (GGC primary care): Ovarian cysts in post-menopausal women (example of local thresholds/RMI approach; not D&amp;G). <a href="https://www.rightdecisions.scot.nhs.uk/ggc-primary-care/womens-health/gynaecology-clinical-guidelines/ovarian-cysts-in-post-menopausal-women-549/">rightdecisions.scot.nhs.uk</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
